GlucoTrack Statistics
Total Valuation
GlucoTrack has a market cap or net worth of $1.55 million. The enterprise value is -$2.38 million.
Important Dates
The next estimated earnings date is Wednesday, May 13, 2026, after market close.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
GlucoTrack has 1.94 million shares outstanding.
| Current Share Class | 1.94M |
| Shares Outstanding | 1.94M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +1.50% |
| Owned by Insiders (%) | 0.65% |
| Owned by Institutions (%) | 3.74% |
| Float | 1.79M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.26 |
| P/TBV Ratio | 0.55 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.61, with a Debt / Equity ratio of 1.22.
| Current Ratio | 1.61 |
| Quick Ratio | 1.55 |
| Debt / Equity | 1.22 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -282.28 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -146.06% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -524.96% |
| Weighted Average Cost of Capital (WACC) | 3.26% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.76M |
| Employee Count | 11 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -91.88% in the last 52 weeks. The beta is 0.61, so GlucoTrack's price volatility has been lower than the market average.
| Beta (5Y) | 0.61 |
| 52-Week Price Change | -91.88% |
| 50-Day Moving Average | 1.23 |
| 200-Day Moving Average | 4.49 |
| Relative Strength Index (RSI) | 40.09 |
| Average Volume (20 Days) | 3,391,989 |
Short Selling Information
The latest short interest is 883,209, so 45.43% of the outstanding shares have been sold short.
| Short Interest | 883,209 |
| Short Previous Month | 43,428 |
| Short % of Shares Out | 45.43% |
| Short % of Float | 49.47% |
| Short Ratio (days to cover) | 0.99 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -16.09M |
| Pretax Income | -19.39M |
| Net Income | -19.39M |
| EBITDA | -16.05M |
| EBIT | -16.09M |
| Earnings Per Share (EPS) | -$31.22 |
Full Income StatementBalance Sheet
The company has $7.38 million in cash and $3.45 million in debt, with a net cash position of $3.94 million or $2.02 per share.
| Cash & Cash Equivalents | 7.38M |
| Total Debt | 3.45M |
| Net Cash | 3.94M |
| Net Cash Per Share | $2.02 |
| Equity (Book Value) | 2.83M |
| Book Value Per Share | 3.11 |
| Working Capital | 2.89M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$15.24 million and capital expenditures -$96,000, giving a free cash flow of -$15.34 million.
| Operating Cash Flow | -15.24M |
| Capital Expenditures | -96,000 |
| Depreciation & Amortization | 42,000 |
| Net Borrowing | 3.00M |
| Free Cash Flow | -15.34M |
| FCF Per Share | -$7.89 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
